Stock Ideas
New
StocksFundsScreenerSectorsWatchlists

Latest Vida Ventures Advisors, LLC Stock Portfolio

$180Million

Equity Portfolio Value
Last Reported on: 12 Apr, 2024

About Vida Ventures Advisors, LLC and it’s 13F Hedge Fund Stock Holdings

In it's latest 13F Holdings report, Vida Ventures Advisors, LLC reported an equity portfolio of $84 Millions as of 31 Dec, 2023.

The top stock holdings of Vida Ventures Advisors, LLC are CNTA, DYN, LIAN. The fund has invested 37.3% of it's portfolio in CENTESSA PHARMACEUTICALS PLC and 32.9% of portfolio in DYNE THERAPEUTICS, INC.

The fund managers got completely rid off PRAXIS PRECISION MEDICINES, INC. (PRAX) stocks. They significantly reduced their stock positions in DYNE THERAPEUTICS, INC. (DYN).

New Buys

Ticker$ Bought
KYVERNA THERAPEUTICS, INC.112,374,000

New stocks bought by Vida Ventures Advisors, LLC

Additions

No additions were made to existing positions by Vida Ventures Advisors, LLC

Reductions

Ticker% Reduced
DYNE THERAPEUTICS, INC.-80.36

Vida Ventures Advisors, LLC reduced stake in above stock

Sold off

Ticker$ Sold
LIANBIO-10,200,900
KINNATE BIOPHARMA, INC.-5,232,420
IKENA ONCOLOGY, INC.-443,628

Vida Ventures Advisors, LLC got rid off the above stocks

Current Stock Holdings of Vida Ventures Advisors, LLC

Last Reported on: 12 Apr, 2024
TickerNamesorted ascending% PortfolioShares Held$ ValueType% ChangeOptions
ALLOALLOGENE THERAPEUTICS, INC.4.461,798,1608,037,790UNCHANGED0.00
CNTACENTESSA PHARMACEUTICALS PLC24.683,931,82044,429,500UNCHANGED0.00
DYNDYNE THERAPEUTICS, INC.6.43407,49911,568,900REDUCED-80.36
IKNAIKENA ONCOLOGY, INC.0.000.000.00SOLD OFF-100
KNTEKINNATE BIOPHARMA, INC.0.000.000.00SOLD OFF-100
KRONKRONOS BIO, INC.2.002,765,3103,594,910UNCHANGED0.00
LIANLIANBIO0.000.000.00SOLD OFF-100
KYVERNA THERAPEUTICS, INC.62.434,523,920112,374,000NEW